A detailed history of Truvestments Capital LLC transactions in Vericel Corp stock. As of the latest transaction made, Truvestments Capital LLC holds 557 shares of VCEL stock, worth $22,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
557
Previous 415 34.22%
Holding current value
$22,202
Previous $17,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$29.84 - $41.74 $4,237 - $5,927
142 Added 34.22%
557 $17,000
Q2 2025

Aug 13, 2025

BUY
$37.92 - $45.7 $15,736 - $18,965
415 New
415 $17,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.88B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.